GLP-1 receptor agonists, already used for Type 2 diabetes and obesity, show promise in reducing alcohol and drug-seeking ...

There is increasing evidence to suggest that GLP-1 drugs may help people cut back on alcohol, smoking, and even opioid use. The medicines, which include semaglutide and tirzepatide, are immensely ...

GLP-1 drugs like Ozempic, Wegovy, and Zepbound are prescribed for weight loss, diabetes, and blood-sugar management. But as more people use them, patients are reporting a decrease in cravings for ...

Could Mounjaro or related drugs treat cannabis use disorder and other substance addictions? Maybe so. GLP-1 receptor agonists like Ozempic and Victoza were originally developed to treat type 2 ...

Add Yahoo as a preferred source to see more of our stories on Google. GLP-1 medications may also fight addiction, says Dr. Ziyad Al-Aly whose team researched trends from GLP-1 use in 600,000 people ...

WashU Medicine researchers find in a new study that GLP-1 use is tied to reductions in substance use disorders and serious outcomes across all types of addictive substances. Researchers at Washington ...

Last fall, United Airlines and Lyft teamed up to offer bonus rewards for members. Now, United members can also redeem miles directly in the Lyft app. Here’s how to take advantage of the new perk.

A popular class of drugs for treating diabetes and obesity may reduce addiction, including abuse of alcohol, tobacco, cannabis, opioids and cocaine, according to research published March 4 by ...

There's new evidence that GLP-1 drugs like Ozempic can reduce the risk of addiction. A study of more than 600,000 veterans followed for up to three years found that those who started taking a GLP-1 ...

Researchers at Washington University School of Medicine in St. Louis show in a new study that GLP-1 medications may be effective at treating and preventing substance use disorders across all major ...